TP53 and metastatic neoplasm: TP53 had the highest SNV frequency in both MMR-d and MMR-p tumors, but its frequency did not differ between MMR-d (33.3%) and MMR-p (37.3%) metastatic tumors (p = 0.56) (Figure 3b,d, Supplementary Table S5).